UPDATE: Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 1c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus

Go back to UPDATE: Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 1c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus

Zimmer Biomet (ZBH) PT Lowered to $101 at Credit Suisse

February 4, 2019 8:41 AM EST

Credit Suisse analyst Matt Miksic lowered the price target on Zimmer Biomet (NYSE: ZBH) to $101.00 (from $102.00) while maintaining a Underperform rating.

... More

Zimmer Biomet (ZBH) PT Raised to $150 at Jefferies; Train is Finally Leaving the Station

February 1, 2019 1:14 PM EST

Jefferies analyst Raj Denhoy raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $140.00) while maintaining a Buy rating following strong Q4.

Denhoy said 'The Train is Leaving the Station (Finally)"

... More

Zimmer Biomet (ZBH) PT Lowered to $128 at RBC Capital

January 30, 2019 6:33 AM EST

RBC Capital analyst Glenn Novarro lowered the price target on Zimmer Biomet (NYSE: ZBH) to $128.00 (from $130.00) while maintaining a Outperform rating.

... More